Imported Disease Annotations - MGIObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | GADD45GIP1 | Human | type 2 diabetes mellitus | | ISS | Gadd45gip1 (Mus musculus) | 13592920 | OMIM:125853 more ... | MouseDO | | |
|
Imported Disease Annotations - MGIObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | GADD45GIP1 | Human | type 2 diabetes mellitus | | ISS | Gadd45gip1 (Mus musculus) | 13592920 | OMIM:125853 more ... | MouseDO | | |
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. | Hayes JD and Dinkova-Kostova AT, Trends Biochem Sci. 2014 Apr;39(4):199-218. doi: 10.1016/j.tibs.2014.02.002. Epub 2014 Mar 16. |
3. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
4. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
GADD45GIP1 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gadd45gip1 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gadd45gip1 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gadd45gip1 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GADD45GIP1 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GADD45GIP1 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gadd45gip1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GADD45GIP1 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GADD45GIP1 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gadd45gip1 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in GADD45GIP1
14 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 19p13.2-13.13(chr19:8831147-13331227)x3 | copy number gain | See cases [RCV000052908] | Chr19:8831147..13331227 [GRCh38] Chr19:8941823..13442041 [GRCh37] Chr19:8802823..13303041 [NCBI36] Chr19:19p13.2-13.13 |
likely pathogenic |
GRCh38/hg38 19p13.2-13.12(chr19:10315258-14048994)x3 | copy number gain | See cases [RCV000052909] | Chr19:10315258..14048994 [GRCh38] Chr19:10425934..14159806 [GRCh37] Chr19:10286934..14020806 [NCBI36] Chr19:19p13.2-13.12 |
pathogenic |
GRCh38/hg38 19p13.2-13.12(chr19:12132052-14751798)x3 | copy number gain | See cases [RCV000052910] | Chr19:12132052..14751798 [GRCh38] Chr19:12242867..14862610 [GRCh37] Chr19:12103867..14723610 [NCBI36] Chr19:19p13.2-13.12 |
pathogenic |
GRCh38/hg38 19p13.13(chr19:12850595-13290954)x3 | copy number gain | See cases [RCV000052911] | Chr19:12850595..13290954 [GRCh38] Chr19:12961409..13401768 [GRCh37] Chr19:12822409..13262768 [NCBI36] Chr19:19p13.13 |
pathogenic |
GRCh38/hg38 19p13.13(chr19:12813597-13119698)x3 | copy number gain | See cases [RCV000054144] | Chr19:12813597..13119698 [GRCh38] Chr19:12924411..13230512 [GRCh37] Chr19:12785411..13091512 [NCBI36] Chr19:19p13.13 |
uncertain significance |
GRCh38/hg38 19p13.2-13.12(chr19:11227942-14532135)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053944]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053944]|See cases [RCV000053944] | Chr19:11227942..14532135 [GRCh38] Chr19:11338618..14642947 [GRCh37] Chr19:11199618..14503947 [NCBI36] Chr19:19p13.2-13.12 |
pathogenic |
GRCh38/hg38 19p13.2-13.13(chr19:11517825-13225287)x1 | copy number loss | See cases [RCV000053945] | Chr19:11517825..13225287 [GRCh38] Chr19:11628640..13336101 [GRCh37] Chr19:11489640..13197101 [NCBI36] Chr19:19p13.2-13.13 |
pathogenic |
NM_052850.3(GADD45GIP1):c.183C>T (p.Phe61=) | single nucleotide variant | Malignant melanoma [RCV000063435] | Chr19:12957030 [GRCh38] Chr19:13067844 [GRCh37] Chr19:12928844 [NCBI36] Chr19:19p13.13 |
not provided |
NM_005053.3(RAD23A):c.754C>T (p.Pro252Ser) | single nucleotide variant | Malignant melanoma [RCV000071939] | Chr19:12949349 [GRCh38] Chr19:13060163 [GRCh37] Chr19:12921163 [NCBI36] Chr19:19p13.13 |
not provided |
GRCh38/hg38 19p13.2-q13.31(chr19:11227942-44626354)x3 | copy number gain | See cases [RCV000133888] | Chr19:11227942..44626354 [GRCh38] Chr19:11338618..45129651 [GRCh37] Chr19:11199618..49821491 [NCBI36] Chr19:19p13.2-q13.31 |
pathogenic |
GRCh38/hg38 19p13.2-13.12(chr19:12580427-14742673)x1 | copy number loss | See cases [RCV000135937] | Chr19:12580427..14742673 [GRCh38] Chr19:12691241..14853485 [GRCh37] Chr19:12552241..14714485 [NCBI36] Chr19:19p13.2-13.12 |
pathogenic|likely pathogenic |
GRCh38/hg38 19p13.2-13.12(chr19:11525163-14155021)x1 | copy number loss | See cases [RCV000136909] | Chr19:11525163..14155021 [GRCh38] Chr19:11635978..14265833 [GRCh37] Chr19:11496978..14126833 [NCBI36] Chr19:19p13.2-13.12 |
pathogenic |
GRCh38/hg38 19p13.2-13.13(chr19:10319474-13777860)x1 | copy number loss | See cases [RCV000141568] | Chr19:10319474..13777860 [GRCh38] Chr19:10430150..13888674 [GRCh37] Chr19:10291150..13749674 [NCBI36] Chr19:19p13.2-13.13 |
pathogenic |
GRCh37/hg19 19p13.2(chr19:12204632-13497073)x1 | copy number loss | See cases [RCV000449161] | Chr19:12204632..13497073 [GRCh37] Chr19:19p13.2 |
pathogenic |
GRCh37/hg19 19p13.2-13.12(chr19:9678768-14853426) | copy number gain | See cases [RCV000446985] | Chr19:9678768..14853426 [GRCh37] Chr19:19p13.2-13.12 |
pathogenic |
GRCh37/hg19 19p13.2-13.12(chr19:12574343-14726197)x1 | copy number loss | See cases [RCV000511130] | Chr19:12574343..14726197 [GRCh37] Chr19:19p13.2-13.12 |
pathogenic |
GRCh37/hg19 19p13.2-13.12(chr19:11608072-14543046)x3 | copy number gain | See cases [RCV000511013] | Chr19:11608072..14543046 [GRCh37] Chr19:19p13.2-13.12 |
uncertain significance |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)x3 | copy number gain | See cases [RCV000511289] | Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic|uncertain significance |
NM_052850.4(GADD45GIP1):c.361A>G (p.Ile121Val) | single nucleotide variant | not specified [RCV004320761] | Chr19:12954516 [GRCh38] Chr19:13065330 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.217G>A (p.Gly73Ser) | single nucleotide variant | not specified [RCV004321387] | Chr19:12956996 [GRCh38] Chr19:13067810 [GRCh37] Chr19:19p13.13 |
uncertain significance |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888) | copy number gain | See cases [RCV000512296] | Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:68029-59110290)x3 | copy number gain | not provided [RCV000752439] | Chr19:68029..59110290 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-59097160)x3 | copy number gain | not provided [RCV000752444] | Chr19:260912..59097160 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
NM_052850.4(GADD45GIP1):c.595A>G (p.Lys199Glu) | single nucleotide variant | not provided [RCV000893768] | Chr19:12954282 [GRCh38] Chr19:13065096 [GRCh37] Chr19:19p13.13 |
benign |
NM_052850.4(GADD45GIP1):c.26G>A (p.Arg9His) | single nucleotide variant | not provided [RCV000845050] | Chr19:12957187 [GRCh38] Chr19:13068001 [GRCh37] Chr19:19p13.13 |
not provided |
GRCh37/hg19 19p13.2(chr19:12354642-13424014)x1 | copy number loss | not provided [RCV000846538] | Chr19:12354642..13424014 [GRCh37] Chr19:19p13.2 |
pathogenic |
NC_000019.9:g.(?_11277234)_(13249220_?)dup | duplication | not provided [RCV003105511] | Chr19:11277234..13249220 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NC_000019.9:g.(?_10828919)_(13482613_?)dup | duplication | Charcot-Marie-Tooth disease dominant intermediate B [RCV003109233]|Deficiency of alpha-mannosidase [RCV003109232]|Episodic ataxia type 2 [RCV003109234]|Glutaric aciduria, type 1 [RCV003122092] | Chr19:10828919..13482613 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NC_000019.9:g.(?_12757434)_(13617038_?)del | deletion | Aicardi-Goutieres syndrome 4 [RCV004579585]|Episodic ataxia type 2 [RCV001953618]|Glutaric aciduria, type 1 [RCV001947065] | Chr19:12757434..13617038 [GRCh37] Chr19:19p13.2 |
pathogenic |
GRCh37/hg19 19p13.2-13.12(chr19:12697728-14111313)x1 | copy number loss | not provided [RCV001834482] | Chr19:12697728..14111313 [GRCh37] Chr19:19p13.2-13.12 |
pathogenic |
NC_000019.9:g.(?_12757434)_(13373667_?)del | deletion | Aicardi-Goutieres syndrome 4 [RCV001923352]|Episodic ataxia type 2 [RCV001923351]|not provided [RCV001923353] | Chr19:12757434..13373667 [GRCh37] Chr19:19p13.2 |
pathogenic|uncertain significance |
NC_000019.9:g.(?_12917488)_(13205463_?)del | deletion | not provided [RCV002016875] | Chr19:12917488..13205463 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.122A>C (p.Asp41Ala) | single nucleotide variant | not specified [RCV004121890] | Chr19:12957091 [GRCh38] Chr19:13067905 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.16C>G (p.Arg6Gly) | single nucleotide variant | not specified [RCV004087381] | Chr19:12957197 [GRCh38] Chr19:13068011 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.55G>A (p.Ala19Thr) | single nucleotide variant | not specified [RCV004186705] | Chr19:12957158 [GRCh38] Chr19:13067972 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.59C>T (p.Pro20Leu) | single nucleotide variant | not specified [RCV004073755] | Chr19:12957154 [GRCh38] Chr19:13067968 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.218G>A (p.Gly73Asp) | single nucleotide variant | not specified [RCV004171492] | Chr19:12956995 [GRCh38] Chr19:13067809 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.560G>A (p.Arg187His) | single nucleotide variant | not specified [RCV004217728] | Chr19:12954317 [GRCh38] Chr19:13065131 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.19C>G (p.Gln7Glu) | single nucleotide variant | not specified [RCV004351239] | Chr19:12957194 [GRCh38] Chr19:13068008 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.197C>T (p.Ala66Val) | single nucleotide variant | not specified [RCV004356204] | Chr19:12957016 [GRCh38] Chr19:13067830 [GRCh37] Chr19:19p13.13 |
uncertain significance |
GRCh37/hg19 19p13.2(chr19:12281048-13573342)x3 | copy number gain | not provided [RCV003485193] | Chr19:12281048..13573342 [GRCh37] Chr19:19p13.2 |
likely pathogenic |
NM_052850.4(GADD45GIP1):c.380A>G (p.Lys127Arg) | single nucleotide variant | not provided [RCV003421848] | Chr19:12954497 [GRCh38] Chr19:13065311 [GRCh37] Chr19:19p13.13 |
likely benign |
GRCh37/hg19 19p13.2(chr19:10441330-13077352)x1 | copy number loss | not specified [RCV003986120] | Chr19:10441330..13077352 [GRCh37] Chr19:19p13.2 |
pathogenic |
NM_052850.4(GADD45GIP1):c.527A>G (p.Gln176Arg) | single nucleotide variant | not specified [RCV004390225] | Chr19:12954350 [GRCh38] Chr19:13065164 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.623C>T (p.Ala208Val) | single nucleotide variant | not specified [RCV004390226] | Chr19:12954254 [GRCh38] Chr19:13065068 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.664T>C (p.Ser222Pro) | single nucleotide variant | not specified [RCV004390227] | Chr19:12954213 [GRCh38] Chr19:13065027 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.290C>A (p.Ala97Glu) | single nucleotide variant | not specified [RCV004390223] | Chr19:12956923 [GRCh38] Chr19:13067737 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.89C>T (p.Pro30Leu) | single nucleotide variant | not specified [RCV004390228] | Chr19:12957124 [GRCh38] Chr19:13067938 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NC_000019.9:g.(?_12757434)_(13387962_?)dup | duplication | Episodic ataxia type 2 [RCV004581140] | Chr19:12757434..13387962 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_052850.4(GADD45GIP1):c.352G>C (p.Glu118Gln) | single nucleotide variant | not specified [RCV004619099] | Chr19:12954525 [GRCh38] Chr19:13065339 [GRCh37] Chr19:19p13.13 |
uncertain significance |
NC_000019.9:g.(?_12651855)_(13373667_?)del | deletion | Episodic ataxia type 2 [RCV004581135] | Chr19:12651855..13373667 [GRCh37] Chr19:19p13.2 |
pathogenic |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
The following QTLs overlap with this region. | Full Report | CSV | TAB | Printer | Gviewer |
WI-11591 |
|
|||||||||||||||||||||||||||||||||||||||||||||
RH41814 |
|
Ensembl Acc Id: | ENST00000316939 ⟹ ENSP00000323065 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_052850 ⟹ NP_443082 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NP_443082 ⟸ NM_052850 |
- UniProtKB: | Q969P9 (UniProtKB/Swiss-Prot), Q8TE51 (UniProtKB/Swiss-Prot), Q8IVM3 (UniProtKB/Swiss-Prot), Q9BSM6 (UniProtKB/Swiss-Prot), Q8TAE8 (UniProtKB/Swiss-Prot) |
- Sequence: |
Ensembl Acc Id: | ENSP00000323065 ⟸ ENST00000316939 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q8TAE8-F1-model_v2 | AlphaFold | Q8TAE8 | 1-222 | view protein structure |
RGD ID: | 6811583 | ||||||||
Promoter ID: | HG_ACW:40070 | ||||||||
Type: | Non-CpG | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | K562 | ||||||||
Transcripts: | GADD45GIP1.BAPR07-UNSPLICED | ||||||||
Position: |
|
RGD ID: | 6795590 | ||||||||
Promoter ID: | HG_KWN:29045 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | NM_052850 | ||||||||
Position: |
|
RGD ID: | 7238759 | ||||||||
Promoter ID: | EPDNEW_H25125 | ||||||||
Type: | initiation region | ||||||||
Name: | GADD45GIP1_1 | ||||||||
Description: | GADD45G interacting protein 1 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:29996 | AgrOrtholog |
COSMIC | GADD45GIP1 | COSMIC |
Ensembl Genes | ENSG00000179271 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Transcript | ENST00000316939 | ENTREZGENE |
ENST00000316939.3 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 6.10.280.120 | UniProtKB/Swiss-Prot |
GTEx | ENSG00000179271 | GTEx |
HGNC ID | HGNC:29996 | ENTREZGENE |
Human Proteome Map | GADD45GIP1 | Human Proteome Map |
InterPro | Damage-induce-interact_sf | UniProtKB/Swiss-Prot |
Damage-induce-interacting_prot | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:90480 | UniProtKB/Swiss-Prot |
NCBI Gene | 90480 | ENTREZGENE |
OMIM | 605162 | OMIM |
PANTHER | GROWTH ARREST AND DNA DAMAGE-INDUCIBLE PROTEINS-INTERACTING PROTEIN 1 | UniProtKB/Swiss-Prot |
PTHR31761 | UniProtKB/Swiss-Prot | |
Pfam | CR6_interact | UniProtKB/Swiss-Prot |
PharmGKB | PA134954784 | PharmGKB |
UniProt | G45IP_HUMAN | UniProtKB/Swiss-Prot |
Q8IVM3 | ENTREZGENE | |
Q8TAE8 | ENTREZGENE | |
Q8TE51 | ENTREZGENE | |
Q969P9 | ENTREZGENE | |
Q9BSM6 | ENTREZGENE | |
UniProt Secondary | Q8IVM3 | UniProtKB/Swiss-Prot |
Q8TE51 | UniProtKB/Swiss-Prot | |
Q969P9 | UniProtKB/Swiss-Prot | |
Q9BSM6 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2015-11-24 | GADD45GIP1 | GADD45G interacting protein 1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 | Symbol and/or name change | 5135510 | APPROVED | |
2012-08-07 | GADD45GIP1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 | GADD45GIP1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 | Symbol and/or name change | 5135510 | APPROVED |